PharmaSource Podcast

Life Science Networks
  • 0.0 (0)
  • LIFE SCIENCES
  • UPDATED WEEKLY
PharmaSource Podcast

Welcome to the PharmaSource podcast: the pharma and biotech podcast that explores the latest trends, challenges, and commercial opportunities shaping the biopharma outsourcing. In each episode we'll be speaking with top executives, researchers, and outsourcing experts, who share their perspectives on topics such as building a smarter, more sustainable supply chain, how to partner with CDMOs, digital transformation, procurement and external manufacturing strategies, and plenty more besides. Make sure to subscribe for your regular dose of pharma insight.

  1. Be ‘Right First Time’: Lessons for Biotech CMC with David Caron, Immunome’s SVP CMC

    5 DAYS AGO

    Be ‘Right First Time’: Lessons for Biotech CMC with David Caron, Immunome’s SVP CMC

    David Caron, Senior Vice-President of CMC, AL102 at Immunome, shares why choosing the right CDMO partner can make or break a biotech’s development timeline: “For biotechs, the main business challenge is to do right the first time. To do this, we need to look at the risks related to each activity.” David Caron brings over three decades of pharmaceutical industry experience across multiple biotechs, with expertise spanning from bench formulation to senior leadership roles. His background includes extensive work with various dosage forms and regulatory requirements across EU and US markets. In this latest episode of the PharmaSource podcast David shares crucial insights on how emerging biotechs can optimize their CDMO partnerships, manage costs effectively, and align CMC strategy with business objectives. David Caron will be sharing advice about how to overcome biotech CMC challenges at CDMO Live 2025. Book your ticket here Read the interview here

    30 min

  2. 18 NOV

    From Platform to Product Development: Integra Therapeutics’ CEO on Scaling Gene Editing

    Dr. Avencia Sánchez-Mejías is CEO and co-founder of Integra Therapeutics, a Barcelona-based biotech company developing next-generation gene-editing tools. With a background in molecular biology and clinical genetics, she brings over 15 years of experience in genetic therapy research across Europe, the US, and Asia. In this exclusive interview, Avencia shares insights on transitioning from academia to entrepreneurship, building a sustainable biotech company, and leveraging strategic partnerships to bring innovative gene therapy solutions to market. “Having a technology that can address genetic conditions and new diseases that today are not treatable, can have a huge impact. Not only for the patient but also for the cost of the health system.”, she says. One of Integra’s most significant strategic decisions was expanding beyond being purely a platform technology company to developing their own therapeutic products. This transition required careful consideration of sustainable growth and market validation strategies. “This is probably one of the most strategic decisions that we had to take,” Avencia explains. “We think hard and long on which first indication should be to be successful. It also changed the type of company that we were. We were very technological, and now we are building therapeutic products. So the kind of talent that you need also changes.” Read full article

    21 min

  3. 13 NOV

    ADC Manufacturing: Are only 5 CDMOs fit for purpose?

    "The reality is, we have a lot of CDMOs don't they really know what they're getting into" says Herman Bozenhardt Herman Bozenhardt, a pharmaceutical manufacturing consultant with decades of experience in facility design and operations, brings a wealth of knowledge from his work with numerous pharmaceutical companies and contract manufacturers. His expertise spans from traditional small molecule drugs to complex biologics and potent compounds. In the latest PharmaSource podcast episode, Herman shares his candid thoughts on the challenges facing the pharmaceutical manufacturing industry, particularly in the rapidly growing field of Antibody-Drug Conjugates (ADCs). He explains why many Contract Development and Manufacturing Organizations (CDMOs) may not be adequately prepared to handle these complex and potent compounds. https://pharmasource.global/content/podcast/adc-manufacturing-why-herman-bozenhardt-believes-only-5-cdmos-are-fit-for-purpose/

    37 min

  4. 7 NOV

    GLP 1s and the Unintended Consequences of the $100 Billion Market

    GLP-1 drugs have become a game-changer in treating obesity and type 2 diabetes, forecast to reach a $100 billion market value by 2029. However, their rapid rise raises important questions about resource allocation in pharmaceutical development and manufacturing, as well as affecting the dynamics between patients, healthcare providers, and biopharma. In the latest episode of the PharmaSource podcast, Ben Locwin, Chief Scientist at Black Diamond Networks, explains that GLP-1 drugs represent a significant breakthrough in the treatment of obesity and diabetes and the unintended consequences they are bringing to the industry. Read the article here

    33 min

  5. 28 OCT

    Virtual Plant Best Practices: Interview with Federica Fraschetti, MSD

    “Treat them as a partner, not just a supplier. It’s a mindset you need to get into.” – Federica Fraschetti, MSD Federica Fraschetti, Associate Director of External Manufacturing at MSD, brings years of experience in the pharmaceutical industry and a passion for optimising partnerships with contract manufacturing organisations (CMOs). In the latest PharmaSource podcast episode, Federica explains why getting supplier relationship management right is a key strategy for driving efficiency and fostering innovation in the biopharma industry. Creating an effective CMC operating model is crucial when working with external partners. Federica emphasises the importance of a clear internal structure that is visible to CMOs: “What is really key is the structure that you have internally and then externally. So what the CMO can see of your structure when dealing with partners,” she explains. MSD utilises a ‘virtual plant team’ model, which includes representatives from key functions such as operations, technology, quality, supply chain, and procurement. This structure provides: Clear supporting model for day-to-day operations with the CMO Established escalation paths Defined roles and responsibilities While it’s ideal to match these roles with counterparts at the CMO, Federica acknowledges that this isn’t always possible. “It doesn’t mean that each function needs to be one-to-one matched at the CMO, but you do need to know where it is matched, even if it is the same person or the same function,” she advises. Read the full interview

    38 min

  6. 23 OCT

    How Sharp is Driving Sustainability in Pharmaceutical Packaging and Clinical Services

    “Sustainability is no longer just a buzzword in the pharmaceutical industry. It’s a critical business imperative,” says Hywel Woolf, Global Sustainability Manager at Sharp Services. “ “We’re seeing it become a golden thread in who organizations are and what they intend to deliver, driven by both compliance requirements and client demand.” Hywel Woolf brings extensive experience in environmental management to his role as Global Sustainability Manager at Sharp Services, a leader in commercial packaging, clinical services, and sterile manufacturing for pharmaceuticals. With a background spanning consultancy, construction, and heavy manufacturing, Hywel now applies his expertise to drive sustainability initiatives across Sharp’s global operations. In a recent interview at CPHI Milan, Hywel shared insights into Sharp’ sustainability journey, highlighting the company’s strategic approach to reducing environmental impact across its diverse business units. He explains how Sharp is tackling the challenges of sustainable packaging, managing scope 3 emissions, and collaborating with suppliers and industry partners to drive positive change in the pharmaceutical supply chain. Read the full article

    15 min

  7. 22 OCT

    How Bristol Myers Squibb Optimises Its Global Manufacturing Network Strategy – Interview with Daniel Hurni

    “Manufacturing network strategy is about connecting the dots and seeing the interconnectivity between different brands,” explains Daniel Hurni, Director of Manufacturing Network Strategy and Business Intelligence at Bristol Myers Squibb (BMS). Daniel Hurni brings years of life sciences expertise to his role at BMS, where he is responsible for shaping overarching manufacturing network strategies across small molecules, biologics, and cell and gene therapy business units. His experience spans technical transfer projects, incident management, and long-term strategic planning. In a the latest episode of the PharmaSource podcast, Daniel shared invaluable insights into the complexities of developing and implementing an effective manufacturing network strategy in the pharmaceutical industry. He explains why a robust long-term manufacturing network strategy is crucial for optimizing costs, improving margins, and ensuring supply chain resilience in an increasingly complex global landscape. Read the full article

    42 min

  8. 20 OCT

    The CPHI Podcast: Conversations from the show floor at CPHI Milan with Recipharm, Tjoapack, Renaissance Lakewood, Ecolab and NovaCina

    Live from CPHI Milan 2024, this episode is a roundup of conversations with a number of key exhibitors Recipharm, Tjoapack, Renaissance Lakewood, Ecolab and NovaCina. As you'll hear, it was a noisy event, so written transcripts are all available on PharmaSource. Jon Reed, Head of Strategic Business Planning at Recipharm discussed the CDMO’s recent strategic moves, including Predictive Modeling and GLP-1 focus. https://pharmasource.global/content/podcast/recipharms-strategic-moves-embracing-predictive-modeling-and-glp-1-trends/ Dexter Tjoa, CEO of Tjoapack, shared insights into the company’s 35 year evolution from a small Dutch contract packaging organisation (CPO) to a global player in pharmaceutical packaging. https://pharmasource.global/content/podcast/tjoapacks-global-expansion-bridging-european-and-us-pharmaceutical-packaging-markets/ Eric Kaneps, Vice President of Sales & Marketing at Renaissance Lakewood, discussed the company’s expansion and focus on nasal spray technology. https://pharmasource.global/content/podcast/renaissance-lakewood-drives-cdmo-innovation-in-nasal-spray-technology/ Craig Cox, Vice President of Global Sales, Bioprocessing at Ecolab, shared insights into the company’s bioprocessing solutions, and how they help support sustainability. https://pharmasource.global/content/podcast/ecolabs-bioprocessing-solutions-addressing-sustainability-and-complexity-in-drug-manufacturing/ Peter Bullard, Senior Vice President of Manufacturing at NovaCina, shared insights into the new Australian CDMO’s unique position in the global pharmaceutical market and 50 year legacy. https://pharmasource.global/content/podcast/novacina-new-australian-cdmo-with-50-year-legacy-in-sterile-manufacturing/

    37 min
See All (107)

About

Welcome to the PharmaSource podcast: the pharma and biotech podcast that explores the latest trends, challenges, and commercial opportunities shaping the biopharma outsourcing. In each episode we'll be speaking with top executives, researchers, and outsourcing experts, who share their perspectives on topics such as building a smarter, more sustainable supply chain, how to partner with CDMOs, digital transformation, procurement and external manufacturing strategies, and plenty more besides. Make sure to subscribe for your regular dose of pharma insight.

Information

  • Creator
    Life Science Networks
  • Years Active
    2023 - 2024
  • Episodes
    107
  • Rating
    Clean
  • Copyright
    © Life Science Networks
  • Show Website
    PharmaSource Podcast

You Might Also Like

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada